Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 142 of 1,261
  1. AR 127448

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Jan 24, 2024 · Expires Jan 19, 2044

    granted
  2. US 11878004

    Method for inhibiting Zika virus infection

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  3. US 11878011

    Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

    RedHill Biopharma Ltd. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  4. US 11879019

    Dual-enzyme responsive peptides

    The Regents of the University of California · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  5. US 11878053

    Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

    IO Biotech ApS · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  6. US 11878998

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  7. US 11878023

    Compositions and methods for delivering pharmaceutical agents

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  8. US 11878062

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  9. US 11879016

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  10. US 11878012

    Compositions and methods for treating traumatic brain injury

    The Board of Regents of the University of Texas System · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  11. US 11879034

    Functionalization of polymer scaffolds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  12. US 11878002

    Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disorders

    The Regents of the University of California · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  13. US 11878074

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  14. US 11878049

    Mitapivat therapy and modulators of cytochrome P450

    Agios Pharmaceuticals, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  15. US 11877989

    Nutritional supplement containing L-α-glycerophosphorylcholine

    Energy Beverages LLC · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  16. US 11878064

    Nanoparticle/peptide method of blocking potassium channels

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  17. US 11878977

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  18. US 11879003

    Methods for increasing T-cell function

    Kyverna Therapeutics, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  19. US 11878964

    Compositions comprising an urolithin compound

    Amazentis SA · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  20. US 11879017

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  21. US 11878961

    Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

    The Board of Regents of the University of Texas System · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  22. WO 2024015441

    EXOSOMES DE LAIT BOVIN POUR L'ADMINISTRATION DE VITAMINE K2 ET L'AUGMENTATION DE LA BIODISPONIBILITÉ

    ABBOTT LAB [US] · Granted Jan 18, 2024 · Expires Jan 13, 2044

    granted
  23. US 11872355

    Medical device for detecting fluid parameters using fluorescent probes

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  24. US 11872203

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.